Antiviral effect of strictinin on influenza virus replication

Antiviral Res. 2010 Oct;88(1):10-8. doi: 10.1016/j.antiviral.2010.06.008. Epub 2010 Jul 6.

Abstract

Strictinin, which is a member of the ellagitanin family of hydrolyzable tannins, prevented replication of human, duck and swine influenza A viruses (IAVs) in vitro at non-toxic concentrations. The addition of strictinin at the same time as IAV inoculation to MDCK cells inhibited viral replication in a dose-dependent manner. Strictinin showed 50% inhibitory concentrations for IAVs from 0.09±0.021 to 0.28±0.037μM (mean±S.E.M.) by the focus-forming assay. Treatment of MDCK cells with strictinin before and after viral inoculation resulted in no significant antiviral activity. Further studies showed that strictinin inhibited IAV-induced hemifusion. However, strictinin exhibited no inhibitory effect against receptor binding, sialidase activity. Strictinin also showed an antiviral effect on influenza B virus and human parainfluenza virus type-1 in vitro. The results indicate that strictinin is a useful antiviral agent.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • Cell Line
  • Dose-Response Relationship, Drug
  • Humans
  • Influenza A virus / drug effects*
  • Influenza A virus / physiology
  • Influenza B virus / drug effects*
  • Influenza B virus / physiology
  • Neuraminidase / antagonists & inhibitors
  • Parainfluenza Virus 1, Human / drug effects*
  • Parainfluenza Virus 1, Human / physiology
  • Phenols / pharmacology*
  • Tannins / pharmacology
  • Virus Attachment / drug effects
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Phenols
  • Tannins
  • strictinin
  • Neuraminidase